首页> 外文期刊>Advanced drug delivery reviews >Advanced screening assays to rapidly identify solubility-enhancing formulations: high-throughput, miniaturization and automation.
【24h】

Advanced screening assays to rapidly identify solubility-enhancing formulations: high-throughput, miniaturization and automation.

机译:先进的筛选分析可快速识别可提高溶解度的配方:高通量,小型化和自动化。

获取原文
获取原文并翻译 | 示例
           

摘要

Development of solubility-enhancing formulations for poorly water-soluble compounds always poses a challenge. Conventional formulation screening assays are potentially time-consuming and labor-intensive and, moreover, require a large amount of a compound; they are not ideal when compound availability and testing time are limited. In recent years, in-vitro screening assays that are rapid, inexpensive, minimally labor-intensive, and require only small quantities of a compound have become available. These advanced assays allow high-throughput automation, miniaturization, and parallel processing, thereby enabling scientists to rapidly identify solubility-enhancing formulations with milligram or sub-milligram quantities of an active pharmaceutical ingredient (API). This article reviews these assays for rapidly screening the aqueous solubility of lead compounds and the solubility-enhancing formulations with limited quantities of API.
机译:为水溶性差的化合物开发提高溶解度的制剂总是带来挑战。常规的制剂筛选测定可能是费时且费力的,而且还需要大量的化合物。当化合物的可用性和测试时间受到限制时,它们不是理想的选择。近年来,已经获得了快速,廉价,最低劳动强度并且仅需要少量化合物的体外筛选测定。这些先进的分析方法可实现高通量自动化,小型化和并行处理,从而使科学家能够快速识别具有毫克或亚毫克量的活性药物成分(API)的溶解度增强制剂。本文回顾了这些分析方法,以快速筛选铅化合物的水溶性和含有限量API的提高溶解度的制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号